Mallinckrodt Investor Relations Material
Latest events
Q1 2023
Mallinckrodt
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Mallinckrodt plc
Access all reports
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company's principal categories of products include pain management assets; branded generics; respiratory assets; and specialty distribution services. It serves healthcare organizations such as hospitals, ambulatory surgery centers (ASCs), nursing homes and physicians' offices. The company was founded in 1867 and is based in Dublin, Ireland.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States